Clinical Efficacy and Mechanism Research of Getong Tongluo Capsule in Ischemic Stroke

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this single‐center, randomized, double‐blind, controlled trial is toclarify the clinical efficacy and safety of Getong Tongluo Capsule in patients withischemic stroke. Combined with gut microbiome and metabolomics techniques, investigatorswill explore whether this medicine exerts neuroprotective effects via the gut‐brain axis.Investigators will further verify its pharmacological mechanism through animalexperiments to provide evidence for its clinical application.
Epistemonikos ID: 2268f7ff7af46f04eef41b586a26bae4d5b9233c
First added on: Jul 09, 2026